Suspension of trading

Valuation eFFECTOR Therapeutics, Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 03:59:01 2024-06-24 EDT			5-day change	1st Jan Change
1.075 ^EUR	+0.47%		-8.12%	-88.97%

24-09-10	Tyra Biosciences Names Doug Warner Chief Medical Officer	MT
24-07-07	EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	334.3	17.91	30.2
Change	-	-94.64%	68.61%
Enterprise Value (EV) ¹	304.6	11.88	32.38
Change	-	-96.1%	172.45%
P/E	18.8x	-0.78x	-0.71x
PBR	19.3x	4.58x	-6.01x
PEG	0x	0x	-0x
Capitalization / Revenue	233,760,757x	5,041,796x	-
EV / Revenue	-	-	-
EV / EBITDA	-9.56x	-0.37x	-0.96x
EV / EBIT	-9.55x	-0.37x	-0.96x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	11	-13.76	-16.37
Distribution rate	-	-	-
Net sales	1.43	3.553	-
EBITDA ¹	-31.87	-32.35	-33.73
EBIT ¹	-31.9	-32.4	-33.84
Net income ¹	15.8	-22.66	-35.81
Net Debt ¹	-29.67	-6.029	2.175
Reference price ²	207.000000	10.690000	11.685000
Nbr of stocks (in thousands)	1,615	1,676	2,585
Announcement Date	3/16/22	3/8/23	3/26/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ARGENX SE	32.76x	8.52x	25.76x	0.06%	55.19B
WUXI APPTEC CO., LTD.	17.19x	5.15x	11.19x	1.75%	45.75B
BIONTECH SE	-17.99x	4.24x	-7.4x	-.--%	22.98B
INSMED INCORPORATED	-36.23x	11.97x	-34.9x	-.--%	20.76B
WUXI BIOLOGICS (CAYMAN) INC.	20.08x	3.91x	10.15x	-.--%	16.26B
GENMAB A/S	21.67x	4.34x	14.36x	-.--%	15.42B
EXELIXIS, INC.	16.41x	4.73x	11.09x	-.--%	13.05B
PHARMAESSENTIA CORPORATION	41.21x	15.94x	46.81x	-.--%	12.45B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-434.11x	29.51x	-3290.08x	-.--%	12.37B
Average	-37.67x	9.81x	-357.00x	0.2%	23.8B
Weighted average by Cap.	-11.93x	8.44x	-179.96x	0.39%